Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.
All News
Advertisement
Advertisement
The label expansion is based on findings from the pivotal phase 3 DELIVER trial in which dapagliflozin reduced the composite CV/HF endpoint in HF patients with HFmrEF or HFpEF.
Your daily dose of clinical news you may have missed.
AACE 2023. Deaths among persons with diabetes in the US related to vascular complications increased from 2001 to 2020, primarily driven by renal complications.
Women's Health Week (May 14-20, 2023) is an ideal opportunity to review the top research, policy shifts, and potential drug approvals that affect your patient panel.
Scott Laker, MD, vice president of the AAPM&R, offers 3 thoughts on what primary care clinicians should think of when they think about PM&R.
Your daily dose of clinical news you may have missed.
Fezolinetant is the first NK3 receptor antagonist approved by the FDA for treatment of moderate-to-severe vasomotor symptoms due to menopause.
USPSTF says start mammograms 10 years earlier, OTC contraceptive coming soon, another antiobesity drug in the wings, and 2 more weekly updates of note.
Brexpiprazole, an atypical antipsychotic, is the first and only medication approved to treat AD-associated agitation, reported in almost half of people with the disease.
Advertisement
Neutralizing antibodies were lowest among Janssen volunteers at 1 month post-vaccination but at 6 months afterward, the picture was much different.
Which state has the highest percentage of teenage drug users? Or the fewest opioid prescriptions? Answers from a new report, here.
Find out where drug abuse is most pronounced and which states are at greatest risk for associated problems, here.
Your daily dose of clinical news you may have missed.
Dr Caroline Apovian reminds primary care clinicians who care for patients with obesity that diet and lifestyle counseling are essential for maximum results.
The telehealth practice adopted in March 2020 at the start of the COVID public health emergency will be extended until November 11, 2023.
The partnership between primary care and PM&R is a tool in each specialty's tool box, with the patient's return to full function the shared goal.
Participants with overweight or obesity had lower testicular volume than their healthy peers, putting them at risk for infertility later in adulthood.
Your daily dose of clinical news you may have missed.
Opill, a progestin-only oral contraceptive, if approved by the FDA, would be the first an only form of birth control in the US available without a physician's prescription.
Advertisement
Advertisement
Advertisement
